Status:
UNKNOWN
Clinical Evaluation of EZVent in Hospitalized Mechanically Ventilated Patients
Lead Sponsor:
Triclinium Clinical Development Middle East and North Africa
Collaborating Sponsors:
ezz medical Industries
Conditions:
Respiratory Failure
Respiratory Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Investigation Device: EZVent Ventilator System is designed for respiratory support in hospitalized mechanical ventilated patients. The Ventilator is designed to be used for adults patients. It is desi...
Eligibility Criteria
Inclusion
- Male or Female, aged 18 years or above.
- Mechanically ventilated Patients (on either VC, PC or CPAP modes).
- Able (in the Investigators opinion) and willing to comply with all study requirements.
- Considered clinically stable, with FiO2 less than 60% and PEEP no greater than 10 cm H2O
Exclusion
- Pregnant Women
- Patients who experienced myocardial infarction within the last 6 weeks.
- Shocked patients, Hemodynamic instability requiring vasopressors, cardiac arrhythmias, terminal malignancy.
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05399017
Start Date
August 1 2022
End Date
August 30 2022
Last Update
June 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Critical Care Unit of Kasr Al-Ainy Hospital
Cairo, Egypt